scholarly journals 73. Crosstalk between progesterone and interleukin 11 signal transduction pathways in human endometrial stromal cells during decidualization

2003 ◽  
Vol 15 (9) ◽  
pp. 73 ◽  
Author(s):  
E. Dimitriadis ◽  
L. A. Salamonsen
Keyword(s):  
Signal Transduction ◽  
Stromal Cells ◽  
Signal Transduction Pathways ◽  
Endometrial Stromal Cells ◽  
Interleukin 11

scholarly journals The Production of Interleukin-11 and Decidualization Are Compromised in Endometrial Stromal Cells Derived from Patients with Infertility

2005 ◽  
Vol 90 (3) ◽  
pp. 1607-1612 ◽  
Author(s):  
Natalia Karpovich ◽  
Petra Klemmt ◽  
Jung Hye Hwang ◽  
J. Enda McVeigh ◽  
John K. Heath ◽  
...  
Keyword(s):  
Stromal Cells ◽  
Endometrial Stromal Cells ◽  
Interleukin 11

The signal transduction pathways via protease activated receptor-1 (PAR-1) in human decidual stromal cells

2015 ◽  
Vol 112 ◽  
pp. 128
Author(s):  
Kaori Goto ◽  
Fumiko Kawabe ◽  
Yasushi Kawano ◽  
Takafumi Utsunomiya ◽  
Hisashi Narahara
Keyword(s):  
Signal Transduction ◽  
Stromal Cells ◽  
Signal Transduction Pathways ◽  
Protease Activated Receptor 1

Interleukin-11 enhances cell survival of decidualized normal human endometrial stromal cells

2001 ◽  
Vol 15 (4) ◽  
pp. 272-278 ◽  
Author(s):  
T. Tanaka ◽  
T. Sakamoto ◽  
M. Miyama ◽  
S. Ogita ◽  
N. Umesaki
Keyword(s):  
Cell Survival ◽  
Stromal Cells ◽  
Endometrial Stromal Cells ◽  
Normal Human ◽  
Interleukin 11

Interleukin 1 beta is induced by interleukin 11 during decidualization of human endometrial stromal cells, but is not released in a bioactive form

2007 ◽  
Vol 73 (1) ◽  
pp. 28-38 ◽  
Author(s):  
Christine A. White ◽  
Evdokia Dimitriadis ◽  
Andrew M. Sharkey ◽  
Chelsea J. Stoikos ◽  
Lois A. Salamonsen
Keyword(s):  
Stromal Cells ◽  
Interleukin 1 ◽  
Interleukin 1 Beta ◽  
Endometrial Stromal Cells ◽  
Interleukin 11

scholarly journals Mesenchymal stem/stromal cells in cancer therapy

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Tianxia Lan ◽  
Min Luo ◽  
Xiawei Wei
Keyword(s):  
Signal Transduction ◽  
Bone Marrow ◽  
Stromal Cells ◽  
Translational Medicine ◽  
Signal Transduction Pathways ◽  
Published Data ◽  
Efficacy And Safety ◽  
Therapeutic Mechanisms ◽  
Tumor Homing ◽  
Special Relevance

AbstractThe multipotent mesenchymal stem/stromal cells (MSCs), initially discovered from bone marrow in 1976, have been identified in nearly all tissues of human body now. The multipotency of MSCs allows them to give rise to osteocytes, chondrocytes, adipocytes, and other lineages. Moreover, armed with the immunomodulation capacity and tumor-homing property, MSCs are of special relevance for cell-based therapies in the treatment of cancer. However, hampered by lack of knowledge about the controversial roles that MSC plays in the crosstalk with tumors, limited progress has been made with regard to translational medicine. Therefore, in this review, we discuss the prospects of MSC-associated anticancer strategies in light of therapeutic mechanisms and signal transduction pathways. In addition, the clinical trials designed to appraise the efficacy and safety of MSC-based anticancer therapies will be assessed according to published data.

Sign in / Sign up

Export Citation Format

Share Document